CN Patent

CN101815503A — 鼻腔鼻窦药物递送气雾剂

Assigned to PARI Pharma GmbH · Expires 2010-08-25 · 16y expired

What this patent protects

本发明公开一种药用气雾剂，其适于将活性化合物递送到鼻、窦口鼻道复合体或鼻旁窦粘膜。所述气雾剂的压力并不恒定，而是在约10赫兹到90赫兹的频率波动。所述气雾剂的另一特征在于，其展现小于约5升/分钟的较低有效流量。所述气雾剂特别适于预防、管理或治疗影响鼻或鼻旁窦的疾病、症状或病状，例如急性和慢性鼻窦炎。

USPTO Abstract

本发明公开一种药用气雾剂，其适于将活性化合物递送到鼻、窦口鼻道复合体或鼻旁窦粘膜。所述气雾剂的压力并不恒定，而是在约10赫兹到90赫兹的频率波动。所述气雾剂的另一特征在于，其展现小于约5升/分钟的较低有效流量。所述气雾剂特别适于预防、管理或治疗影响鼻或鼻旁窦的疾病、症状或病状，例如急性和慢性鼻窦炎。

Drugs covered by this patent

Patent Metadata

Patent number
CN101815503A
Jurisdiction
CN
Classification
—
Expires
2010-08-25
Drug substance claim
No
Drug product claim
No
Assignee
PARI Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.